Excler JL. 2015. HIV prevention & treatment--reasons to rejoice & remain vigilant. Indian J Med Res 142(6):633-6. PMID: 26831409.
Paris RM, Petrovas C, Ferrando-Martinez S, Moysi E, Boswell KL, Archer E, Yamamoto T, Ambrozak D, Casazza JP, Haubrich R, Connors M, Ake J, Kim JH, Koup RA. 2015. Selective loss of early differentiated, highly functional PD1 high CD4 T Cells with HIV progression. PLoS One 10(12):e0144767. PMID: 26678998.
Peachman KK, Karasavvas N, Chenine AL, McLinden R, Rerks-Ngarm S, Jaranit K, Nitayaphan S, Pitisuttithum P, Tovanabutra S, Zolla-Pazner S, Michael NL, Kim JH, Alving CR, Rao M. 2015. Identification of new regions in HIV-1 gp120 variable 2 and 3 loops that bind to α4β7 integrin receptor. PLoS One 10(12):e0143895. PMID: 26625359
Arabi Y, Balkhy H, Hajeer AH, Bouchama A, Hayden FG, Al-Omari A, Al-Hameed FM, Taha Y, Shindo N, Whitehead J, Merson L, AlJohani S, Al-Khairy K, Carson G, Luke TC, Hensley L, Al-Dawood A, Al-Qahtani S, Modjarrad K, Sadat M, Rohde G, Leport C, Fowler R. 2015. Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol. Springerplus 4:709. PMID: 26618098.
Harbertson J, Scott PT, Moore J, Wolf M, Morris J, Thrasher S, D'Onofrio M, Grillo MP, Jacobs MB, Tran BR, Tian J, Ito SI, McAnany J, Michael N, Hale BR. 2015. Sexually transmitted infections and sexual behaviour of deploying shipboard US military personnel: a cross-sectional analysis. Sex Transm Infect 91(8):581-8. PMID: 26586849.
Bolton DL, Pegu A, Wang K, McGinnis K, Nason M, Foulds K, Letukas V, Schmidt SD, Chen X, Todd JP, Lifson JD, Rao S, Michael NL, Robb ML, Mascola JR, Koup RA. 2015. Human immunodeficiency virus type 1 monoclonal antibodies suppress acute simian-human immunodeficiency virus viremia and limit seeding of cell-associated viral reservoirs. J Virol 90(3):1321-32. PMID: 26581981.
Pacha LA, Hakre S, Myles O, Sanders-Buell EE, Scoville SL, Kijak GH, Price MW, Mody RM, Liu Y, Miller SL, Pham PT, Michael NL, Kim JH, Peel SA, Tovanabutra S, Jagodzinski LL, Cersovsky SB, Scott PT. 2015. Centralized HIV program oversight: an investigation of a case series of new HIV infections among US Army Soldiers, 2012 to 2013. Medicine (Baltimore) 94(46):e2093. PMID: 26579822.
Ndhlovu LC, D'Antoni ML, Ananworanich J, Byron MM, Chalermchai T, Sithinamsuwan P, Tipsuk S, Ho E, Slike BM, Schuetz A, Zhang G, Agsalda-Garcia M, Shiramizu B, Shikuma CM, Valcour V. 2015. Loss of CCR2 expressing non-classical monocytes are associated with cognitive impairment in antiretroviral therapy-naïve HIV-infected Thais. J Neuroimmunol. 288:25-33. PMID: 26531691.
Brett-Major DM, Frick KD, Malia JA, Hakre S, Okulicz JF, Beckett CG, Jagodinski LL, Forgione MA, Gould PL, Harrison SA, Murray CK, Rentas FJ, Armstrong AW, Hayat AM, Pacha LA, Dawson P, Eick-Cost AA, Maktabi HH, Michael NL, Cersovsky SB, Peel SA, Scott PT. 2015. Costs and consequences: Hepatitis C seroprevalence in the military and its impact on potential screening strategies. Hepatology 63(2):398-407. PMID: 26481723.
Ngwuta JO, Chen M, Modjarrad K, Joyce MG, Kanekiyo M, Kumar A, Yassine HM, Moin SM, Killikelly AM, Chuang GY, Druz A, Georgiev IS, Rundlet EJ, Sastry M, Stewart-Jones GB, Yang Y, Zhang B, Nason MC, Capella C, Peeples ME, Ledgerwood JE, McLellan JS, Kwong PD, Graham BS. 2015. Prefusion F-specific antibodies determine the magnitude of RSV neutralizing activity in human sera. Sci Transl Med 7(309):309ra162. PMID: 26468324.
Storcksdieck genannt Bonsmann M, Niezold T, Temchura V, Pissani F, Ehrhardt K, Brown EP, Osei-Owusu NY, Hannaman D, Hengel H, Ackerman ME, Streeck H, Nabi G, Tenbusch M, Überla K. 2015. Enhancing the quality of antibodies to HIV-1 envelope by GagPol-specific Th cells. J Immunol 195(10):4861-72. PMID: 26466954.
Ananworanich J, Barré-Sinoussi F. 2015. Is it time to abandon single intervention cure trials? Lancet HIV. 2(10):e410-1. PMID: 26423646.
Dominique JK, Ortiz-Osorno AA, Fitzgibbon J, Gnanashanmugam D, Gilpin C, Tucker T, Peel S, Peter T, Kim P, Smith S. 2015. Implementation of HIV and tuberculosis diagnostics: the importance of context. Clin Infect Dis 61Suppl 3:S119-25. PMID: 26409272.
Beck Z, Matyas GR, Jalah R, Rao M, Polonis VR, Alving CR. 2015. Differential immune responses to HIV-1 envelope protein induced by liposomal adjuvant formulations containing monophosphoryl lipid A with or without QS21. Vaccine 33(42):5578-87. PMID: 26372857.
Rutstein SE, Sellers CJ, Ananworanich J, Cohen MS. 2015. The HIV treatment cascade in acutely infected people: informing global guidelines. Curr Opin HIV AIDS. 10(6):395-402. PMID: 26371460.
Baldwin, K.M., Ehrenberg, P.K., Geretz, A., Prentice, H.A., Nitayaphan, S., Rerks-Ngarm, S., Kaewkungwal, J., Pitisuttithum, P., O'Connell, R.J., Kim, J.H., Thomas, R. HLA class II diversity in HIV-1 uninfected individuals from the placebo arm of the RV144 Thai vaccine efficacy trial. Tissue Antigens February 2015. doi:10.1111/tan.12507.
Prentice H.A., Tomaras G.D., Geraghty D.E., Apps R., Fong Y., Ehrenberg P.K., Rolland M., Kijak G.H., Krebs S.J., Nelson W., DeCamp A., Shen X., Yates N.L., Zolla-Pazner S., Nitayaphan S., Rerks-Ngarm S., Kaewkungwal J., Pitisuttithum P., Ferrari G., McElrath M.J., Montefiori D.C., Bailer R.T., Koup R.A., O'Connell R.J., Robb M.L., Michael N.L., Gilbert P.B., Kim J.H., Thomas R. HLA class II genes modulate vaccine-induced antibody responses to affect HIV-1 acquisition. Sci Transl Med, July 15 2015. doi:10.1126/scitranslmed.aab4005.
Valcour, V. G., Spudich, S. S., Sailasuta, N., Phanuphak, N., Lerdlum, S., Fletcher, J. L., Kroon, E. D. M. B., Jagodzinski, L. L., Allen, I. E., Adams, C. L., Prueksakaew, P., Silke, B. M., Hellmuth, J. M., Kim, J. H., & Ananworanich, J. Neurological response to cART vs. cART plus integrase inhibitor and CCR5 antagonist initiated during acute HIV. PloS one, May 14 2015. doi:10.1371/journal.pone.0142600.
Olwenyi, O.A., Naluyima, P., Cham, F., Quinn, T.C., Serwadda, D., Sewankambo, N.K., Gray, R.H., Sandberg, J.K., Michael, N.L., Wabwire-Mangen, F., Robb, M.L., Eller, MA. Differential associations of IL-6 and intestinal fatty acid-binding protein with progressive untreated HIV-1infection in Rakai, Uganda. Journal of Acquired Immune Deficiency Syndromes, Dec 1 2015. doi:10.1097/QAI.0000000000000915.
Krebs, S.J., Ananworanich, J. Immune activation during acute HIV infection and the impact of early antiretroviral therapy. Current Opinion in HIV and AIDS, Nov 21 2015. doi:10.1097/COH.0000000000000228.
Ndahimana, J.D., Riedel, D.J., Muhayimpundu, R., Nsanzimana, S., Niyibizi, G., Mutaganzwa, E., Mulindabigwi, A., Baribwira, C., Kiromera, A., Jagodzinski, L.L., Peel, S.A., Redfield, R.R. HIV drug resistance mutations among patients failing second-line antiretroviral therapy in Rwanda. Antiviral Therapy, Nov 12 2015. doi:10.3851/IMP3005.
Chung, A.W., Kumar, M.P., Arnold, K.B., Yu, W.H., Schoen, M.K., Dunphy, L.J., Suscovich, T.J., Frahm, N., Linde, C., Mahan, A.E., Hoffner, M., Streeck, H., Ackerman, M.E., McElrath, M.J., Schuitemaker, H., Pau, M.G., Baden, L.R., Kim, J.H., Michael, N.L., Barouch, D.H., Lauffenburger, D.A., Alter, G. Dissecting polyclonal vaccine-induced humoral immunity against HIV using Systems Serology. Cell, 5 Nov 2015. doi:10.1016/j.cell.2015.10.027.
Janes, H., Herbeck, J., Tovanabutra, S., Thomas, R., Frahm, N., Duerr, A., Hural, J., Corey, L., self, S., Buchbinder, S., McElrath, J., O’Conell, R., Paris, R., Rerks-Ngarm, S., Nitayaphan, S., Pitisuttihum, P., Kaewkungwal, J., Robb, M., Michael, NL., Mullins, J., Kim, J., Gilbert, P., Rolland, M. HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders. Nature Medicine. 31 Aug 2015. doi: 10.1038/nm.3932
Manak, M., Njoku, O., Shutt, A., Malia, J., Jagodzinski, L., Milazzo, M., Suleiman, A., Ogundejim A., Nelson, R., Ayemoba, O., O’Connell, R., Singer, D., Michael, N., Peel, S. Evaluation of the performance of two HIV-1/2 rapid tests in high and low prevalence populations in Nigeria. JMC 26 Aug 2015 doi: 10.1128/MC.01432-15.
Ying, H., Identifying optimal biomarker combinations for treatment selection through randomized controlled trials. Clin Trials. Aug 2015. Vol 12 no. 4 348-356. doi:10.11777/1740774515580126.
Graham, B., Modjarrad, K., McLellan, J., Novel antigens for RSV vaccines. Current Opinions. Vol. 35, Aug. 2015, pg 30-38. Doi:10.1016/j.coi.2015.04.005.
Sailasuta N, Ananworanich J, Lerdlum S, Sithinamsuwan P, Fletcher JLK, Tipsuk S, Pothisri M, Jadwattanakul T, Jirajariyavej S, Chalermchai T, Catella S, Busovaca E, Desai A, Paul R, Valcour V on behalf of the SEARCH 011 Study Group. Neuronal-glia markers by Magnetic Resonance Spectroscopy in HIV Before and After Combination Antiretroviral Therapy. JAIDS, Aug 6
Santra, S., Tomaras, GD., Warrier, R., Nicely, NI., Liao, HX., Pollara, J., Liu, P., Alam, SM., Zhang, R., Cocklin, SL., Shen, X., Duffy, R., Xia, SM., Schutte, RJ., Pemble, IV Cw., dennison, Sm., Li, H., Chao, A., Vidnovic, K., Evans, A., Klein, K., Kumar, A., Robinson, J., Landucci, G., Forthal, DN., Montefiori, DC., Kaewkungwal, J., Nitayaphan, S., Pitisuttithum, P., Rerks-Ngarm, S., Robb, ML., Michael, NL., Kim, JH., Soderberg, KA., Giorgi, EE., Blair, L., Korber, BT., Moog, C., Shattock, RJ., Letvin, NL., Schmitz, JE., Moody, MA., Gao, F., Ferari, G., Shaw, GM., Haynes, BF. Human Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus Macaques. PLoS Pathog. 2015 Aug 3;11(8):e1005042. doi: 10.1371/journal.ppat.1005042. eCollection 2015 Aug.
Prasitsuebsai W, Kerr SJ, Truong KH, Ananworanich J, Do VC, Nguyen LV, Kurniati N, Kosalaraksa P, Sudjaritruk T, Chokephaibulkit K, Thammajaruk N, Singtoroj T, Teeraananchai S, Horng H, Bacchetti P, Gandhi M, Sohn AH. Using Lopinavir Concentrations in Hair Samples to Assess Treatment Outcomes on Second-Line Regimens Among Asian Children.AIDS Res Hum Retroviruses. 2015 Aug 26.
Karasavvas N, Karnasuta C, de Souza MS, Inthawong D, Savadsuk H, Madnote S, Chantakulkij S, Rittiroongrad S, Nitayaphan S, Pitisuttithum P, Thongcharoen P, Siriyanon V, Andrews C, Barnett SW, Tartaglia J, Sinangil F, Francis DP, Robb M, Michael NL, Ngauy V, Paris RM, Excler DJ, Kim JH, O'Connell RJ. IgG Antibody Responses to Recombinant gp120 proteins, gp70V1/V2 Scaffolds and a CyclicV2 Peptide in Thai Phase I/II Vaccine Trials using Different Vaccine Regimens. AIDS Res Hum Retroviruses. 2015 Aug 2. [Epub ahead of print]
Nicely, NI, Wiehe, K., Kepler, TB., Jaeger, FH., Dennison, SM., Rerks-Ngarm, S., Nitayaphan, S., Pitisuttithum, P., Kaewkungwal, J., Robb, ML., O’Connell, RJ., Michael, NL., Kim, JH., Liao, HX., Munir Alam, S., Hwang, KK., Bonsignoir, M., Haynes, BF. Structural analysis of the unmutated ancestor of the HIV-1 envelope V2 region antibody CHI58 isolated from an RV144 vaccine efficacy trial vaccine. EBioMedicine. 2015 Jun 20;2(7):713-22. doi: 10.1016/j.ebiom.2015.06.016. eCollection 2015 Jul.
Sunshine JE, Larsen BB, Maust B, Casey E, Deng W, Chen L, Westfall DH, Kim M, Zhao H, Ghorai S, Lanxon-Cookson E, Rolland M, Collier AC, Maenza J, Mullins JI, Frahm N. Fitness-balanced escape determines resolution of dynamic founder virus escape processes in HIV-1 infection. J Virol. 2015 Jul 29. pii: JVI.01876-15. [Epub ahead of print]
Sikazwe I, Elafros MA, Bositis CM, Siddiqi OK, Koralnik IJ, Kalungwana L, Theodore WH, Okulicz JF, Potchen MJ, Birbeck GL. HIV and new onset seizures: slipping through the cracks in HIV care and treatment. HIV Med. 2015 Jul 22. doi: 10.1111/hiv.12283. [Epub ahead of print]
Ananworanich, J., What Will It Take to Cure HIV? Top Antivir Med. 2015 Jay – 23; 23 (2): 80-4.
Klein N, Palma P, Luzuriaga K, Pahwa S, Nastouli E, Gibb DM, Rojo P, Borkowsky W, Bernardi S, Zangari P, Calvez V, Compagnucci A, Wahren B, Foster C, Munoz-Fernández MÁ, De Rossi A, Ananworanich J, Pillay D, Giaquinto C, Rossi P. Early antiretroviral therapy in children perinatally infected with HIV: a unique opportunity to implement immunotherapeutic approaches to prolong viral remission. Lancet Infect Dis. 2015 Jul 14. pii: S1473-3099(15)00052-3. doi: 10.1016/S1473-3099(15)00052-3. [Epub ahead of print] Review.
Kancheva Landolt N, Bunupuradah T, Achalapong J, Kosalaraksa P, Petdachai W, Ngampiyaskul C, Auchieng C, Ananworanich J, Boonyanurak P. Premenstrual disorders among perinatally HIV-infected adolescents. J Acquir Immune Defic Syndr. 2015 Jul 15. [Epub ahead of print]
Rolland, M., Modjarrad, K. Multiple co-circulating HIV-1 subtypes in the Middle East and North Africa. AIDS. 2015 Jul 17; 29 (11): 1417-9. Doi: 10.1097/QAD.00000000764.
Hakre, S., Scoville, S., Pacha, L., Peel, S., Kim, JH, Michael, NL., Cersovsky, SB., Scott, PT. Sexual Risk Behaviors of HIV Seroconverters in the U.S. Army, 2012-2014. J Acquir Immune Defic Syndr. 2015. Jul 31. [Epub ahead of print]
Lo YR, Chu C, Ananworanich J, Excler JL, Tucker JD. Stakeholder Engagement in HIV Cure Research: Lessons Learned from Other HIV Interventions and the Way Forward. AIDS Patient Care STDS. 2015 Jul;29(7):389-99. doi: 10.1089/apc.2014.0348. Epub 2015 May 18.
Schwartz SR, Nowak RG, Orazulike I, Keshinro B, Ake J, Kennedy S, Njoku O, Blattner WA, Charurat ME, Baral SD; TRUST Study Group. The immediate effect of the Same-Sex Marriage Prohibition Act on stigma, discrimination, and engagement on HIV prevention and treatment services in men who have sex with men in Nigeria: analysis of prospective data from the TRUST cohort. Lancet HIV. 2015 Jul 1;2(7):e299-e306.
Allam A, Majji S, Peachman K, Jagodzinski L, Kim J, Ratto-Kim S, Wijayalath W, Merbah M, Kim JH, Michael NL, Alving CR, Casares S, Rao M. TFH cells accumulate in mucosal tissues of humanized-DRAG mice and are highly permissive to HIV-1. Sci Rep. 2015 Jun 2;5:10443. doi: 10.1038/srep10443.
Jahanshad N, Couture MC, Prasitsuebsai W, Nir TM, Aurpibul L, Thompson PM, Pruksakaew K, Lerdlum S, Visrutaratna P, Catella S, Desai A, Kerr SJ, Puthanakit T, Paul R, Ananworanich J, Valcour VG; SEARCH 012 and the PREDICT Study Groups. Brain Imaging and Neurodevelopment in HIV-Uninfected Thai Children Born to HIV-Infected Mothers. Pediatr Infect Dis J. 2015 Jun 18.
Phanuphak, J., Lo. YR., Sho, Y., Solomon, SS., O’Connell, RJ., Tovanabutra, S., Chang, D., Kim, JH., Excler, JL. HIV Epidemic in Asia: Impilcations for HIV Vaccine and Other Prevention Trials. AIDS Res Hum Retroviruses. 2015 Jun 24 [Epub ahead of print].
Pitisuttithum P, Rerks-Ngarm S, Stablein D, Dawson P, Nitayaphan S, Kaewkungwal J, Michael NL, Kim JH, Robb ML, O'Connell RJ, Yoon IK, Fernandez S, Excler JL. Accuracy of Clinical Diagnosis of Dengue Episodes in the RV144 HIV Vaccine Efficacy Trial in Thailand. PLoS One. 2015 May 26;10(5):e0127998. doi: 10.1371/journal.pone.0127998. eCollection 2015.
Kore, I., Ananworanich, J., Valcour, V., Fletcher, J., Chalermchi, T., Paul, R., Reynolds, J., Tipsuk, S., Ubolyam, S., Rattanamanee, S>, Jagodzinski, L., Kim, J., Spudich, S., RV254/SEARCH010 Study Group. Neropsychological impairment in acute HIV and the effect of immediate antiretroviral therapy. JAIDS. 2015 June 30 doi: 10.1097/QAI.00000000746.
Lin L, Finak G, Ushey K, Seshadri C, Hawn TR, Frahm N, Scriba TJ, Mahomed H, Hanekom W, Bart PA, Pantaleo G, Tomaras GD, Rerks-Ngarm S, Kaewkungwal J, Nitayaphan S, Pitisuttithum P, Michael NL, Kim JH, Robb ML, O'Connell RJ, Karasavvas N, Gilbert P, C De Rosa S, McElrath MJ, Gottardo R. COMPASS identifies T-cell subsets correlated with clinical outcomes. Nat Biotechnol. 2015 Jun;33(6):610-6. doi: 10.1038/nbt.3187. Epub 2015 May 25.
Peluso MJ, Valcour V, Ananworanich J, Sithinamsuwan P, Chalermchai T, Fletcher JL, Lerdlum S, Chomchey N, Slike B, Sailasuta N, Gisslén M, Zetterberg H, Spudich S; RV254/SEARCH 010 and SEARCH 011 Study Teams. Absence of Cerebrospinal Fluid Signs of Neuronal Injury Before and After Immediate Antiretroviral Therapy in Acute HIV Infection. J Infect Dis. 2015 May 20. pii: jiv296. [Epub ahead of print]
Excler JL., Robb, ML., Kim JH. Prospects for a globally effective HIV-1 vaccine. Vaccine. 2015 Jun 20: doi: 10.1016/j.vaccine.2015.03.059
Jalah R, Torres OB, Mayorov AV, Li F, Antoline JF, Jacobson AE, Rice KC, Deschamps JR, Beck Z, Alving CR, Matyas GR. Efficacy, but not antibody titer or affinity, of a heroin hapten conjugate vaccine correlates with increasing hapten densities on tetanus toxoid, but not on CRM197 carriers. Bioconjug Chem. 2015 Jun 17;26(6):1041-53. doi: 10.1021/acs.bioconjchem.5b00085. Epub 2015 Jun 5.
Brown, E., Normandin, E., Osei-Owusu, N., Mahan, A., Chan, Y., Lai, J., Vaccari, M., Rao, M., Franchini, G., Alter, G., Ackerman, M. Microsale purification of antigen-specific antibodies. J Immunol Methods 2015 Jun 12. doi: 10.1016/j.jim.2015.06.005
Wang, L., Shi, W., Hoyce, G., Modjarrad, K., Zhang, Y., Leung, K., Lees, C., Zhou, T., Yassine, H., Kanekiyo, M., Yang, Z., Chen, X., Becker, M., Freeman, M., Vogel, L., Johnson, J., Olinger, G., Todd, J., Bagci, U., Solomon, J., Mollura, D., Hensley, L, Jahrling, P., Denison, M., Rao, S., Subbararo, K., Kwong, P., Mascola, J., Kong, W., Graham, B. Evaluation of Candidate vaccine approaches for MERS-CoV Nature Communications 28 July 2015 doi:10.1038/ncomms8712
Hakre S, Mydlarz DG, Dawson P, Danaher PJ, Gould PL, Witkop CT, Michael NL, Peel SA, Scott PT, Okulicz JF. Epidemiology of HIV among US Air Force Military Personnel, 1996-2011. PLoS One. 2015 May 11;10(5):e0126700. doi: 10.1371/journal.pone.0126700. eCollection 2015.
Phanuphak N, Teeratakulpisarn N, van Griensven F, Chomchey N, Pinyakorn S, Fletcher JL, Trichavaroj R, Pattanachaiwit S, Michael N, Phanuphak P, Kim JH, Ananworanich J; RV254/SEARCH 010 Study Group. Anogenital HIV RNA in Thai men who have sex with men in Bangkok during acute HIV infection and after randomization to standard vs. intensified antiretroviral regimens. J Int AIDS Soc. 2015 May 7;18:19470. doi: 10.7448/IAS.18.1.19470. eCollection 2015.
Kancheva Landolt N, Phanuphak N, Khongpetch C, Kriengsinyot R, Teeratakulpisarn S, Ubolyam S, Kerr S, Pinyakorn S, Chaithongwongwatthana S, Phanuphak P, Avihingsanon A, Ananworanich J. Low uptake of HIV testing and no HIV positivity in stable serodiscordant heterosexual partners of long-term treated HIV-infected Thais. IDS Care. 2015 May;27(5):587-94. doi: 10.1080/09540121.2014.989485.
Shikuma CM, Bennett K, Ananworanich J, Gerschenson M, Teeratakulpisarn N, Jadwattanakul T, DeGruttola V, McArthur JC, Ebenezer G, Chomchey N, Praihirunkit P, Hongchookiat P, Mathajittiphun P, Nakamoto B, Hauer P, Phanuphak P, Phanuphak N; SEARCH 003 protocol team. Distal leg epidermal nerve fiber density as a surrogate marker of HIV-associated sensory neuropathy risk: risk factors and change following initial antiretroviral therapy. J Neurovirol. 2015 May 22.
Crowell, T., Hatano, H., Clinical outcomes and antiretroviral therapy in ‘elite’ controllers: a review of the literature. JVE 2015. 1:72-77.
Clark DV, Kibuuka H, Millard M, Wakabi S, Lukwago L, Taylor A, Eller MA, Eller LA, Michael NL, Honko AN, Olinger GG Jr, Schoepp RJ, Hepburn MJ, Hensley LE, Robb ML. Long-term sequelae after Ebola virus disease in Bundibugyo, Uganda: a retrospective cohort study. Lancet Infect Dis. 2015 Aug;15(8):905-12. doi: 10.1016/S1473-3099(15)70152-0. Epub 2015 Apr 21.
Joachim, A., Nilsson, C., Aboud, S., Bakari, M., Lyamuya, E., Rob, M., Marvich, M., Earl, P., Moss, B., Ochsenbauer, C., Wahren, B., Mhalu, F., Sandstrom, E., Biberfeld, G., Ferrari, G., Polonis, VR. Potent functional antibody responses elicited by HIV-1 DNA priming and boosting with heterologous HIV-1 recombinanat MVA in healthy Tanzanian adults. PLOS One. 2015 April 14; 10 (4): e0118466. Doi: 10.1371/journal.pone.0118486 ecollection 2015.
DeSouza MS, Phanuphak N, Pinyakorn S, Trichavaroj R, Pattanachaiwit S, Chomchey N, Fletcher JLK, Kroon ED, Michael NL, Phanuphak P, Kim JH, Ananworanich J on behalf of the RV254/SEARCH010 Study Group. Impact of nucleic acid testing relative to antigen/antibody combination immunoassay on the detection of acute HIV infection. AIDS. 2015 Apr 24;29(7):793-800.
Ananworanich J, Chomont N, Fletcher JLK, Pinyakorn S, Schuetz A, Sereti I, Rerknimitr R, Dewar R, Kroon E, Vandergeeten C, Trichavaroj R, Chomchey N, Chalermchai T, Michael N, Kim JH, Phanuphak P, Phanuphak N on behalf of the RV254/SEARCH 010 Study Group. Markers of HIV reservoir size and immune activation after treatment in acute HIV infection with and without raltegravir and maraviroc intensification. Journal Virus Eradication April 2015
Ramautarsing RA, Phanuphak N, Chaithongwongwatthana S, Wit FWNM, Teeraratakulpisarn N, Pankam T, Rodbamrung P, van de Wijgert JH, Lange JMA, Phanuphak P, Sahasrabudda VV, Kerr SJ, Ananworanich J and the Thai Women’s HPV Study Group. Cervical and anal HPV infection: cytological and histological abnormalities in HIV-infected women in Thailand.Journal Virus Eradication, April 2015: 1:96-102
Phanuphak N, Paris R, Colby D, Pinyakorn S, de Souza M, Teeraratakulpisarn N, Chomchey N, Sutthichom D, Sukjitpaibookphol A, Pankam T, Kim JH, Ananworanich J, Phanuphak P on behalf of the RV233/SEARCH008 study group. Low incidence of HIV infection in an anonymous HIV counselling and testing clinic cohort in Bangkok, Thailand despite high HIV prevalence and self-report of high-risk behavior. Journal Virus Eradication, April 2015: 1: 89-95
Choi I, Chung AW, Suscovich TJ, Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, O'Connell RJ, Francis D, Robb ML, Michael NL, Kim JH, Alter G, Ackerman ME, Bailey-Kellogg C. Machine learning methods enable predictive modeling of antibody feature:function relationships in RV144 vaccinees. PLoS Comput Biol. 2015 Apr 13;11(4):e1004185. doi: 10.1371/journal.pcbi.1004185. eCollection 2015 Apr.
Rhee SY, Blanco JL, Jordan MR, Taylor J, Lemey P, Varghese V, Hamers RL, Bertagnolio S, Rinke de Wit TF, Aghokeng AF, Albert J, Avi R, Avila-Rios S, Bessong PO, Brooks JI, Boucher CA, Brumme ZL, Busch MP, Bussmann H, Chaix ML, Chin BS, D'Aquin TT, De Gascun CF, Derache A, Descamps D, Deshpande AK, Djoko CF, Eshleman SH, Fleury H, Frange P, Fujisaki S, Harrigan PR, Hattori J, Holguin A, Hunt GM, Ichimura H, Kaleebu P, Katzenstein D, Kiertiburanakul S, Kim JH, Kim SS, Li Y, Lutsar I, Morris L, Ndembi N, Ng KP, Paranjape RS, Peeters M, Poljak M, Price MA, Ragonnet-Cronin ML, Reyes-Terán G, Rolland M, Sirivichayakul S, Smith DM, Soares MA, Soriano VV, Ssemwanga D, Stanojevic M, Stefani MA, Sugiura W, Sungkanuparph S, Tanuri A, Tee KK, Truong HH, van de Vijver DA, Vidal N, Yang C, Yang R, Yebra G, Ioannidis JP, Vandamme AM, Shafer RW. Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysis. PLoS Med. 2015 Apr 7;12(4):e1001810. doi: 10.1371/journal.pmed.1001810. eCollection 2015 Apr.
Langley CL, Lapidos-Salaiz I, Hamm TE, Bateganya MH, Firth J, Wilson M, Martin J, Dierberg K. Prioritizing HIV care and support interventions-moving from evidence to policy. J Acquir Immune Defic Syndr. 2015 Apr 15;68 Suppl 3:S375-8. doi: 10.1097/QAI.0000000000000545. Review.
Anand, T., Nitpolprasert, C., Ananworanich, J., Pakam, C., Siriporn, N., Janatarapakde, J. Innovative Strategies Using Communications Technologies to Engage Gay Men and Other Men who Have Sex with men into early HIV testing and treatment in Thailand. JVE. Apr 2015; 1(2): 111
Stabinski L, OʼConnor S, Barnhart M, Kahn RJ, Hamm TE. Prevalence of HIV and hepatitis B virus co-infection in sub-Saharan Africa and the potential impact and program feasibility of hepatitis B surface antigen screening in resource-limited settings.J Acquir Immune Defic Syndr. 2015 Apr 15;68 Suppl 3:S274-85. doi: 10.1097/QAI.0000000000000496. Review.
Kaplan JE, Hamm TE, Forhan S, Saadani Hassani A, Bang G, Weyant E, Tchuenche M, Langley C, Lapidos-Salaiz I, Bateganya MH. The impact of HIV care and support interventions on key outcomes in low- and middle-income countries: a literature review--introduction. J Acquir Immune Defic Syndr. 2015 Apr 15;68 Suppl 3:S253-6. doi: 10.1097/QAI.0000000000000495.
Heaps JM, Sithinamsuwan P, Paul R, Lerdlum S, Pothisri M, Clifford D, Tipsuk S, Catella S, Busovaca E, Fletcher JL, Raudabaugh B, Ratto-Kim S, Valcour V, Ananworanich J; on behalf of the SEARCH 007/011 study groups. Association between brain volumes and HAND in cART-naïve HIV+ individuals from Thailand. J Neurovirol. J Neurovirol. 2015 Apr;21(2):105-12
Baral SD, Ketende S, Schwartz S, Orazulike I, Ugoh K, Peel SA, Ake J, Blattner W, Charurat M. Evaluating respondent-driven sampling as an implementation tool for universal coverage of antiretroviral studies among men who have sex with men living with HIV. J Acquir Immune Defic Syndr. 2015 Mar 1;68 Suppl 2:S107-13. doi: 10.1097/QAI.0000000000000438.
Zhang L, Phanuphak N, Henderson K, Nonenoy S, Srikaew S, Shattock AJ, Omune B, van Griensven F, Osornprasop S, Smutraprapoo P, Oelrichs R, Ananworanich J, Wilson DP. Scaling up HIV treatment for MSM in Bangkok: what does it take? a modelling and costing study. Lancet HIV 2015
Ananworanich, J. Treatment interruption and predictors for viraemic control. JVE Mar 2015
Tansiri Y, Rowland-Jones SL, Ananworanich J, Hansasuta P. Clinical Outcome of HIV Viraemic Controllers and Noncontrollers with Normal CD4 Counts Is Exclusively Determined by Antigen-Specific CD8+ T-Cell-Mediated HIV Suppression. PLoS One. 2015 Mar 12;10(3):e0118871.
Streeck H. AIDS virus seeks refuge in B cell follicles. Nat Med. 2015 Feb;21(2):111-2. doi: 10.1038/nm.3795
Edlefsen PT, Rolland M, Hertz T, Tovanabutra S, Gartland AJ, deCamp AC, Magaret CA, Ahmed H, Gottardo R, Juraska M, McCoy C, Larsen BB, Sanders-Buell E, Carrico C, Menis S, Bose M; RV144 Sequencing Team, Arroyo MA, O'Connell RJ, Nitayaphan S, Pitisuttithum P, Kaewkungwal J, Rerks-Ngarm S, Robb ML, Kirys T, Georgiev IS, Kwong PD, Scheffler K, Pond SL, Carlson JM, Michael NL, Schief WR, Mullins JI, Kim JH, Gilbert PB. Comprehensive sieve analysis of breakthrough HIV-1 sequences in the RV144 vaccine efficacy trial. PLoS Comput Biol. 2015 Feb 3;11(2):e1003973. doi: 10.1371/journal.pcbi.1003973. eCollection 2015 Feb.
O'Bryan TA, Rini EA, Okulicz J, Messner O, Ganesan A, Lalani T, Bavaro MF, O'Connell RJ, Agan BK, Landrum ML. HIV viraemia during hepatitis B vaccination shortens the duration of protective antibody levels. HIV Med. 2015 Mar;16(3):161-7. doi: 10.1111/hiv.12189. Epub 2015 Jan 14.
Ananworanich J, Sirivichayakul S, Pinyakorn S, Crowell TA, Trichavaroj R, Weerayingyong J, Chomchey N, Fletcher JL, van Griensven F, Phanuphak P, Robb ML, Michael NL, Kim JH, Phanuphak N. High prevalence of transmitted drug resistance in acute HIV-infected Thai men who have sex with men. J Acquir Immune Defic Syndr. 2015 Apr 1;68(4):481-5. doi: 10.1097/QAI.0000000000000502.
Ananworanich J, Prasitsuebsai W, Kerr SJ, Hansudewechakul R, Teeratakulpisarn N, Saisawat K, Ramautarsing R, Achalapong J, Pussadee K, Keadpudsa S, Mackay T, Pankam T, Rodbamrung P, Petdachai W, Chokephaibulkit K, Sohn AH, Phanuphak N on behalf of the HIV-NAT 139 Study Group. Cervical cytological abnormalities and HPV infection in perinatally HIV-infected adolescents. J Virus Erad. 2015 Jan;1(1):30-37.